{"name":"Regend Therapeutics","slug":"regend-therapeutics","ticker":"","exchange":"","domain":"regend.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"REGEND007","genericName":"REGEND007","slug":"regend007","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"REGEND007","genericName":"REGEND007","slug":"regend007","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQQ1RoLWM1Skk4Y2xOUUo1eDJkNFJhZWRZV2N0eEZmV2hfci1uS2tvVjRiNTV1TUVrWGVBMXZzc2J0dnpQS0xma0dKZ0lUUThZRzd6ZTJZZHUzVF85SE5VcGlrdG5iWUVpRHZrUEdrYkJGZURZQ2IwRl9TOHZwLVdVQ0NXc2R3dnRxUDdIcllNaC14RjBRZEg3MmQ0aHlhNllSbkVaSC12Vld5eU9ZX2NnNnhJdlRJamhiaXNZMHFMNmdkcE1rMlVzRkxRaUo5enhJbUtvTFBJTzN1WkxtUC03elZnUWllTlQ1QnE3YkNVNjd6WlZiSnZLWnIwSWRPdnpnYTAwUUJrbUlndy1hSlZlTGJ4ZEZtRnBIMVRMMFpR?oc=5","date":"2026-03-30","type":"trial","source":"Barchart.com","summary":"Chronic Obstructive Pulmonary Disease Clinical Trial Pipeline Appears Robust With 65+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com","headline":"Chronic Obstructive Pulmonary Disease Clinical Trial Pipeline Appears Robust With 65+ Key Pharma Companies Actively Work","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxNVFpieWVrTlg2eTRIZTVmUmZ6MEhYTlZZMHg4cHU4ME1pUWp0SjlkRHBJcVA0S1l3VjdBeXl1Wk8wNmZLYVJzSWxuY1YxRWg0c05Ec3BhdlNoZkNsdnR4MEFmUGdWUHZIV0lBMlJFbW4tZWQ4OVVubFhWbHloSnpjb0tqN3RtZ0pTNmxXM2RGQ01VUFIxMG04QTMycHEwaERjTkR0UGlrdHEydkJlemcwUlBUalEtaWlxTjVzZkJ4LUc1czNiSTIyM2VjMi1rRm8xZU5FWTZTaUhtT0N0UUVwd2xNUWVjY2xYVVlCYUwtbkUzSzB5dTVqTnQ2SDFYcG5sNkZLN09KU2xURG8tRHpod0EyVGE?oc=5","date":"2026-03-19","type":"trial","source":"Barchart.com","summary":"Pulmonary Fibrosis Clinical Trial Analysis 2026: 110+ Companies Advancing 140+ Therapies with Breakthrough Clinical Progress, analyses DelveInsight - Barchart.com","headline":"Pulmonary Fibrosis Clinical Trial Analysis 2026: 110+ Companies Advancing 140+ Therapies with Breakthrough Clinical Prog","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxOdm90RzFBMHJuOEwya29VbGhyb2dLMTRscWFmSzdjN0F2LVpGMENiYVE5MXZRbXIxdVNJMU84VXdQY04yREFZbkE4QmVjdlkxTVZEZzdSSF9xYzF1SGl4aDBRV2N3OW9qNU5uNzFRa09LZUJkWWVrQlJ0VHVPR0dnMFRmMDBQOF82ZTlKak94WUhCelhNeFFIa0ZkdlhzUHl4c3VEUlotWUxiMmxnNndhQUY2QVQ4TWxMeTRycTFIbFFqVlpMcHg3b0IwUE9Ya19hSmUwaElxaGdNWDNDRk5CVUxzb0N3R3p5dXQ1c21sanYzYXhWSmpJenkwUGxqUHRMTlpDMy1JYl9KV3B2dTZtU29kdzg4LXNaLXNWRkdGemZoa19pQTQ5aWlNbE50MmZwMFhfdlduZ3VlZVZ1Qk1WaV9VcVBLal9JaWN5U2VwMFdVLUl0?oc=5","date":"2026-02-26","type":"regulatory","source":"Barchart.com","summary":"Pulmonary Fibrosis Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma, Tvardi Therapeutics ","headline":"Pulmonary Fibrosis Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsig","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE5lYmRINThMamRmcjF2RjllODBoWFNpMXdSeTVoTkNTc0FDVjk2Y3ROd1ZWUWY2R1hrYnBwWlNKbTh0ZlVfVnlweWcxRDI2WE52dXNSaFI2R1kyc1drQ0pTekZiSGhJVllja09sZHFSbWttZC1IdE1z?oc=5","date":"2025-12-10","type":"pipeline","source":"labiotech.eu","summary":"Promising cure for COPD: Is a breakthrough treatment within reach? - labiotech.eu","headline":"Promising cure for COPD: Is a breakthrough treatment within reach?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOODJxY2ZybWxEdzhXVzJucGZPQ0xLc2NfVlQwNEV5d2IyZTJqN2w3engzWFJxVXBsSVRKcnZFSE83bU9JWWZKQmFnMk5IOUpidV9acm9qT0FVMEYwVFI3TGtKVEE4ajhBbjFvMHFBcXdKdnQzVGd2c0ZQSnAwTHQ4dGNrWHNKeUZETEM1MUNFRlVYMURqZkEwQnV4c3I3NktpOVVaV0ZPeklOSG8wSk9KMy1IVGNlTnEtNTJPbnZmTQ?oc=5","date":"2025-11-12","type":"pipeline","source":"Fierce Pharma","summary":"UPDATED: J&J, Legend withdraw ASH abstract assessing Carvykti against Gilead, Arcellx's rival CAR-T - Fierce Pharma","headline":"UPDATED: J&J, Legend withdraw ASH abstract assessing Carvykti against Gilead, Arcellx's rival CAR-T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPREpoZXZMN3IxUk82Q0JULTNPa0YxZHgxU3NCdm5jSFRvYUpPU3Ayckk5dnhQVWcyMzYzekZ0UC1LMUxKdmpPRFlXTjNidnVWeHBtc1hFV2xvUTU2dzFQMk1XTFF5WG9YMWNCZVFrelc3RHV4VzEtZWZrSXRmX01DNUpQUGFEZHpobm8yOGQ5UVhTTFFoaWR2NTl0dFI2YnpCYWIyV1Uwb2RldDVUMXFadQ?oc=5","date":"2025-09-17","type":"pipeline","source":"Fierce Pharma","summary":"Merck pitches heart disease awareness campaign with assist from St. Louis Cardinals - Fierce Pharma","headline":"Merck pitches heart disease awareness campaign with assist from St. Louis Cardinals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNQVVmSjNHbFBlb3dLcGZYVk93NEhLbDRkaGNyVUtpQzhRQzJFNlVxTHlVdDhkTXppTEJlSUMzZFU1VzBQWXEzVXZoWTNEZmdSZGRxaUZrOUtfTUhZbEtaWUExVTIwR216YUtJczJneHFYYlNoQ0JfU25Hdk9yZUhuMk12SFEwSmhlNV8xRXpRTXNBM2lkZ3hTLVAzYmVzS2luRGxZQi1BZC1iX21hcVdJTDRB?oc=5","date":"2025-08-27","type":"pipeline","source":"PR Newswire","summary":"American Regent® Launches Gvoke VialDx™ (glucagon injection) - PR Newswire","headline":"American Regent® Launches Gvoke VialDx™ (glucagon injection)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOQi0xTGhvalJJSmhtMFJCSldfeTQwVFVMLUZrVUxLXzJUZzRHaEJWV08wSm9yLVhVekZ3NEJiZFJ5eUdYc21OakgtcmlheWtfNGRFeTJ5R0E2VlBDTjktaVowUGVrTy1SU044Tnd1LXJ0QTZ1SnJXYUFXVUNvMW1EYzB1WjlvcE8xVThaNkpYRlhVT1M1OEJOZHdIaw?oc=5","date":"2025-06-03","type":"pipeline","source":"PharmTech.com","summary":"UC Berkeley Awards $200K Venture Grant to HypO2Regen Therapeutics - PharmTech.com","headline":"UC Berkeley Awards $200K Venture Grant to HypO2Regen Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1hODB3M01nSk5TRzFVNUxqX2dhODJDXzkxUXZMcGpRWTZOQV93MGs1d1hTeXdMVDN1R2xRSWtHeV9ZNHQ4eklQN2NoTThTdkNBcVZaZGVmc2k5bmZzVlRBYkJ3RXN2R0lMZ0VZazA2cllOcFV5WUhUaTI2SmNWZw?oc=5","date":"2025-02-03","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Top 10 Takeover Targets of 2025 - Genetic Engineering and Biotechnology News","headline":"Top 10 Takeover Targets of 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxPODR6a0JUUjQ2d3pHa2c0M3gtN2ZRMDVGandaRFJha3VIMjg3OEdjWTRZTk1uMlV4Z3ktQUhXZGgxNW9oYmRPQ29NSlpwYklHenlyOElhTnhHTENKZldhZ1JiZ3RWU19CLW5vRUVGWEpneEs4dGY5V1gxRnhHanA2Ni1qQno5SnkyZG40dWxyYWVzVFM4Z2hKaHJqTlg2OEkzTnhMd0hveW5vdEhiRENMVEFxTlVtV1ZwejdjVHhnVlYtR1lhbDVuRzU3YlVETDR3bjhhZm40LWVNcUpKQVdpY2FHZl9JTWQ2VDVRR19KdjFVd1o5RUQzOERDMkZQcEpLWTNwZVJtcjgzR2ppYUJRS01kMnUxOUpLSDlwWFVHT19EaVZDSFhaS2F5cHpNa0MwZjcwVXY1X0dSejgwNUE?oc=5","date":"2025-01-28","type":"trial","source":"GlobeNewswire","summary":"Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust - GlobeNewswire","headline":"Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQN19kOC1Hc2JtQnJsdDIycWNoSHdrR1ItYjYzSUctaGVFeWtkQmRuRS1GYzVZdkFUY2xlRkpEZ0dSYV83dlRLTHExMDlRZkU4OHdSbGY1MHNwZmQwVVFZVmViVW1kS2gyQ1pxdHEyU1NGX2c0V3J3UV9KV1p1M0FzS0JTTnNfcEpUdWd5eTBtdWJMQUItOHF1LWZCZUtaQQ?oc=5","date":"2024-10-03","type":"pipeline","source":"Fierce Biotech","summary":"Legend set to open Philadelphia cell therapy R&D site next year - Fierce Biotech","headline":"Legend set to open Philadelphia cell therapy R&D site next year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQRlJVamthM0NEeV80UDE1TmNTTUtUU3ZBaDV4STB4Vnc3akJqcWFrU3I1cGtEUWM3Wmh5TC1Rem5zYk1sb1M1ZFM5WFFNTjF1dHhkN01ELWxUaXdmUGZoNG9CdWN3YW1JQVNIUW9tUENPZ1hFV0dFN2llSm1kZFByamZvcW1HUXM0Rno0aEt6WFBocWZ1Qkp6ZHlLNHFid0ZkVkxNaWI0RlQwblhIX1RHNWF0LTFHa2xxSDl0TUlqaC1zX2lJZEVySzFQNVZmSElnLTJZQUtRQTg?oc=5","date":"2023-11-09","type":"pipeline","source":"respiratory-therapy.com","summary":"Transplanting COPD Patients’ Own Cells Restores Lung Function - respiratory-therapy.com","headline":"Transplanting COPD Patients’ Own Cells Restores Lung Function - respiratory","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}